Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ironwood Pharmaceuticals Inc. logo

Ironwood Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

8.62
 
USD
  
0.30
  
(3.61%)
Optionable: Yes  Market Cap: 1,302 M  90-day average vol: 4,881,868

Previous close: 8.32  Open: 8.31  Bid: 8.31  Ask: 8.7
52 week range    
8.08   
   15.70
Peers   
AZN / 
SYN / 
NKTR / 
Last updated: Thursday 28th March 2024
41
MarketXLS Rank
40
Value
15
Technical
68
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AZN

CPIX

0 B-843.47

NKTR

2 B-4.110.58

SYN

0 B-0.80.2845
Financials

IRWD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles981000.06 M8 M800000.0
Basic EPS from continuing operations0.381.343.261.13-6.45
Basic EPS total0.141.343.261.13-6.45
Basic weighted shares outstanding137 M142 M145 M149 M153 M156 M159 M162 M154 M155 M
BasicDiscontinuousOperations-0.24
Cost of sales-5 M-12000.0-2 M-19 M-33 M24 M3 M44000.0160 M-1,114 M
Depreciation-12 M-12 M-10 M-8 M-4 M6 M2 M2 M1 M1 M
Depreciation unreconciled981000.06 M8 M
DepreciationAndAmortization-12 M-12 M981000.06 M8 M6 M2 M2 M1 M1 M
Diluted EPS total-1.39-1.0-0.56-0.78-1.850.381.323.210.96-6.45
Diluted normalized net income/share0.381.323.210.96-6.45
Diluted weighted shares outstanding136 M143 M146 M150 M153 M161 M164 M186 M155 M
DilutedDiscontinuousOperations-0.58
Earnings from equity interest-3 M
EarningsFromEquityInterestNetOfTax-3 M
GainOnSaleOfPPE204000.0-694000.02 M
GainOnSaleOfSecurity10 M-10 M8 M-3 M-9 M6 M-5 M-452000.010 M19 M
GainsLossOnDisposalOfDiscontinuedOperations-88 M
GeneralAndAdministrativeExpense-6 M-12 M172 M140 M111 M116 M158 M
Gross operating profit51 M132 M272 M279 M314 M405 M386 M414 M411 M1,557 M
ImpairmentOfCapitalAssets152 M
Income before tax-190 M-143 M-82 M-117 M-194 M59 M109 M201 M252 M-948 M
Income restructuring and M&A-4 M15 M4 M15 M-854000.017 M
Income taxes-154 M-2 M3 M-328 M77 M83 M
Interest income-20 M-41 M-30 M-40 M-43 M
InterestExpenseNonOperating21 M31 M39 M36 M38 M37 M29 M31 M8 M22 M
InterestExpenseOperating7 M7 M6 M
MinorityInterests652 M29 M
MiscOtherSpecialCharges661000.0-2 M-67 M-30 M24000.0-32 M2 M-3 M
Net income from total operations-190 M-143 M-82 M-117 M-282 M22 M106 M528 M175 M-1,002 M
NetIncomeCommonStockholders-190 M-143 M-82 M-117 M-282 M8 M137 M528 M175 M-1,002 M
NetIncomeContinuousOperations-190 M-143 M-82 M-117 M-282 M22 M106 M528 M175 M-1,002 M
NetIncomeDiscontinuousOperations-88 M-37 M
NetNonOperatingInterestIncomeExpense-21 M-31 M-38 M-34 M-35 M-37 M-29 M-31 M-8 M-22 M
Normalized income-732 M
Operating income-169 M-102 M-42 M-109 M-15 M120 M143 M232 M250 M-945 M
Operating income before depreciation (EBITDA)-153 M-91 M-16 M-50 M-127 M121 M171 M264 M269 M-923 M
OperatingExpense220 M234 M314 M388 M329 M287 M228 M182 M160 M274 M
Other income net-661000.010 M2 M-26 M-22 M25 M5 M452000.0-10 M-19 M
OtherGainLossFromDispositionOfDiscontinuedOperations-37 M
OtherGandA-6 M-12 M172 M140 M111 M116 M158 M
OtherImpairmentOfCapitalAssets-152 M
OtherOperatingExpenses-18 M-26 M-24 M-39 M-52 M-67 M-83 M-101 M-85 M
RentAndLandingFees-6 M-12 M
Research & development expense102 M109 M139 M148 M101 M115 M88 M70 M44 M116 M
ResearchExpense102 M109 M139 M148 M101 M115 M88 M70 M44 M116 M
RestructringAndMnAIncome-4 M15 M4 M15 M-854000.017 M
Revenue per share981000.06 M8 M21 M22 M2 M800000.0
SalariesAndWages-26 M-25 M-29 M-34 M-41 M22 M-2 M-3 M
Selling Gen & administrative expense118 M125 M173 M233 M220 M172 M140 M111 M116 M158 M
SellingAndMarketingExpense118 M125 M173 M233 M220 M
SellingExpense118 M125 M173 M233 M220 M
Special income/charges4 M-167 M-4 M-15 M854000.0-17 M
Total Income available for interest expense (EBIT)-168 M-112 M-43 M-81 M-156 M96 M146 M239 M266 M-926 M
Total common shares outstanding141 M143 M148 M151 M155 M158 M161 M159 M154 M157 M
Total net income-190 M-143 M-82 M-117 M-282 M22 M106 M528 M175 M-1,002 M
Total ordinary shares157 M157 M157 M157 M157 M157 M157 M157 M157 M157 M
Total revenues76 M150 M274 M298 M347 M428 M390 M414 M411 M443 M
TotalExpenses215 M234 M312 M368 M296 M311 M231 M182 M321 M-839 M
TotalRevenue76 M150 M109000.0298 M347 M428 M390 M414 M411 M443 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University